References
- Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer127(12) , 2893–2917 (2010).
- Rustgi AK . The genetics of hereditary colon cancer. Genes Dev.21(20) , 2525–2538 (2007).
- Watson AJ , CollinsPD. Colon cancer: a civilization disorder. Dig. Dis.29(2) , 222–228 (2011).
- Tjalsma H , BoleijA, MarchesiJR, DutilhBE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat. Rev. Microbiol.10(8) , 575–582 (2012).
- Grivennikov SI , GretenFR, KarinM. Immunity, inflammation, and cancer. Cell140(6) , 883–899 (2010).
- Rubin DC , ShakerA, LevinMS. Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer. Front. Immunol.3 , 107 (2012).
- Lakatos PL , LakatosL. Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies. World J. Gastroenterol.14(25) , 3937–3947 (2008).
- Terzić J , GrivennikovS, KarinE, KarinM. Inflammation and colon cancer. Gastroenterology138(6) , 2101–2114.E2105 (2010).
- Grivennikov SI , KarinM. Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage. Ann. Rheum. Dis.70(Suppl. 1) , I104–I108 (2011).
- Kim S , KekuTO, MartinC et al. Circulating levels of inflammatory cytokines and risk of colorectal adenomas. Cancer Res. 68(1) , 323–328 (2008).
- Gounaris E , TungCH, RestainoC et al. Live imaging of cysteine-cathepsin activity reveals dynamics of focal inflammation, angiogenesis, and polyp growth. PLoS One 3(8) , e2916 (2008).
- Becker C , FantiniMC, SchrammC et al. TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21(4) , 491–501 (2004).
- Vivier E , SpitsH, CupedoT. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat. Rev. Immunol.9(4) , 229–234 (2009).
- Sugimoto K , OgawaA, MizoguchiE et al. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118(2) , 534–544 (2008).
- Gounaris E , BlatnerNR, DennisK et al. T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis. Cancer Res. 69(13) , 5490–5497 (2009).
- Khazaie K , ZadehM, KhanMW et al. Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 109(26) , 10462–10467 (2012).
- Gareau MG , ShermanPM, WalkerWA. Probiotics and the gut microbiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol.7(9) , 503–514 (2010).
- Mohamadzadeh M , PfeilerEA, BrownJB et al. Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid. Proc. Natl Acad. Sci. USA 108(Suppl. 1) , 4623–4630 (2011).